Report: The U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics,and Surgical Equipment TOC

INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- SCOPE AND FORMAT
- ANALYST CREDENTIALS
- DISCLAIMER
SUMMARY
- Summary Table:
- U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Summary Figure:
- U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
INDUSTRY OVERVIEW
- VISION
  - STRUCTURE OF THE EYE
  - PATHOLOGY
- POPULATION GROWTH AND DEMOGRAPHICS
- Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
- Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
  - OPHTHALMIC CONDITIONS AND DISEASES
    - DIABETIC RETINOPATHY
    - AGE-RELATED MACULAR DEGENERATION
    - OCULAR ALLERGIES
    - HERPES SIMPLEX VIRUS KERATITIS
    - CYTOMEGALOVIRUS RETINITIS
    - CATARACTS
    - GLAUCOMA
- Table 2 GLAUCOMA TYPES AND KEY POINTS
  - UVEITIS
- Table 3 KNOWN CAUSES OF UVEITIS
  - TRACHOMA
  - RETINAL DETACHMENT
  - DRY EYE SYNDROME
  - STRABISMUS
- Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
  - OCULAR MUSCLE SPASMS
    - ISSUES AFFECTING THE MARKET
  - LITIGATION
    - The FDA' s Precautions Involving LASIK Eye Surgery
  - OPHTHALMIC PHARMACEUTICAL AND DEVICE COUNTERFEITING
  - OPHTHALMIC PHARMACEUTICAL/DEVICE RECALLS AND LABEL UPDATES
- Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
  - GOVERNMENT INTERACTION
- Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR MANUFACTURERS
  - S. 2480: CONTACT LENS CONSUMER PROTECTION ACT
  - S. 172
  - FAIRNESS TO CONTACT LENS CONSUMERS ACT
- ADVERTISING
- Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED STATES FOR 2005 ($)
  - PHARMACEUTICAL SIDE EFFECTS AND OPHTHALMIC CONDITIONS
- Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
PRODUCT MARKETS
- PRESCRIPTION OPHTHALMIC PHARMACEUTICALS
  - PRODUCT DESCRIPTIONS
    - Anti-Inflammatory Drugs
- Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY MANUFACTURER AND FDA APPROVAL DATE
  - Research and Development
  - Anti-Infectives
- Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA APPROVAL DATE
- Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER AND DEVELOPMENT PHASE, 2006
  - Antihistamines and Mast Cell Stabilizers
- Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
  - Beta- Adrenergic Blockers
- Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA APPROVAL DATE
  - Research and Development
- Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
  - Prostaglandins
- Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
  - Other Pharmaceutical Treatments
    - Carbonic Anhydrase Inhibitors
    - Dry Eye Treatments
  - Miotics
    - Mydriatics and Cycloplegics
    - Ocular Anesthetics
      - Ocular Muscle Spasm Treatments
      - Pain Management Treatments
      - Vasoconstrictors
      - Other Treatments
- Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
  - RESEARCH AND DEVELOPMENT
- Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
  - MARKET SIZE AND GROWTH
- Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (PERCENT/ $ MILLION)
- Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (%)
- Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURER REVENUES, 2006 ($ MILLION)
- Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURERS REVENUES, 2006 (%)
  - OPHTHALMIC DIAGNOSTICS
    - PRODUCT DESCRIPTIONS
      - Visual Acuity Test
      - Dilated Eye Exam
      - Manifest Refraction
      - Pupil Reflex
      - Tonometry Test
      - Ophthalmoscopy
      - Gonioscopy
      - Slit Lamp Examinations
      - Fluorescein Staining
      - Eye Muscle Tests
      - Corneal Thickness
      - Pachymetry
      - Echography
      - Imaging Diagnostics
        
        Optic Nerve Imaging
        Optic Nerve Computer Imaging
        Aberrometer
        Innovative Imaging, Inc. and Echography
        Corneal Topography
        Flourescein Angiography
        Slit-Lamp Photography
- Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
  - Specular Microscopy
  - Glaucoma-Scope
  - Fundus Cameras
    - MARKET SIZE AND GROWTH
- Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
- Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
  - COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
- Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%)
  - VISION CORRECTION AND VISION PRESERVATION DEVICES
    - PRODUCT DESCRIPTIONS
      - Soft (Disposable) Lenses
      - Gas Permeable Lenses
      - Cosmetic Lenses
      - Shaping Lenses
    - MARKET SIZE AND GROWTH
- Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011 ($ MILLION)
- Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
  - COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (PERCENT/ $ MILLION)
- Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (%)
  - SURGICAL EQUIPMENT
    - PRODUCT DESCRIPTIONS
      - Corneal Procedures
        
        Intracorneal Rings
        Cornea Transplants (Penetrating keratoplasty)
        Deep Anterior Lamellar Corneal Transplant (DLEK)
        DSEK (Descemet' s Stripping with Endothelial Keratoplasty)
      - Lens Procedures
        
        Verisyse Lens Implant
        Lens Replacements
      - Refractive Procedures
        
        Mechanical Microkeratome
        Blade-Free Microkeratome
        Lasek, LASIK, and PRK
      - Retinal Procedures
        
        Vitreo-Retinal Surgery
      - Surgical Procedures for Cataracts
        
        Phacoemulsification Cataract Surgery
        Endocapsular Tension Ring
- Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
  - Surgical Procedures for Glaucoma
    - Glaucoma Implant
    - Neodymium: YAG Laser Cyclophotocoagulation (YAG CP)
    - Diode Laser Transscleral Cyclophotocoagulation (Diode CYC)
    - Selective Laser Trabeculoplasty (SLT)
    - Argon Laser Trabeculoplasty (ALT)
    - Laser Peripheral Iridotomy (LPI)
    - Filtering Microsurgery
  - Procedures for Age-Related Macular Degeneration (AMD)
    - Focal Laser Treatment and PDT
  - Ophthalmic Lasers
    - Blade-Free Femtosecond Microkeratome
- Table 29 MICROKERATOME/ FEMTOSECOND SYSTEMS BY MANUFACTURER
  - Excimer Laser
- Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
  - Nd: Yag Lasers
- Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
  - Other Laser Systems
    - Intraocular Lenses and Other Lens Implants
    - Shunts and Other Drainage Devices
  - RESEARCH AND DEVELOPMENT
  - MARKET SIZE AND GROWTH
- Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
- Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
  - COMPETITIVE STRUCTURE AND MARKET SHARE
- Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (%)
  - MARKET SUMMARY
    - TOTAL OPHTHALMIC MARKET
- Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
- Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($ MILLION)
  - TOTAL MARKET PERCENTAGE DISTRIBUTION BY MARKET SEGMENT
- Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($ MILLION)
- Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)
  - INDUSTRY PARTICIPANTS BY PRODUCT
- Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
  - Competitive Analysis
- Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
TECHNOLOGY
- CURRENT USES OF TECHNOLOGY
  - ADVANCED MEDICAL OPTIC' S WAVESCAN/ CUSTOMVUE TECHNOLOGY
  - CRYSTALENS BY EYEONICS, INC.
  - HYBRID LENSES BY SYNERGEYES, INC.
  - SILICONE HYDROGEL
- Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
  - VISTAKON' S SENOFILCON A LENS
  - VISTAKON' S HIGHLY PERMEABLE LENS TECHNOLOGY
  - IMPLANTABLE CONTACT LENSES (PHAKIC IOL)
  - RETISERT IMPLANT BY BAUSCH & LOMB
  - ORTHOKERATOLOGY
  - NIKE MAXSIGHT
  - TORSIONAL PHACOEMULSIFICATION
  - PATENT EVALUATION BY DRUG
- Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
- Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS, 2006-2019
  - PATENT EVALUATION BY TECHNOLOGY
- Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
  - NEW TECHNOLOGY DEVELOPMENT
COMPANY PROFILES
- ADVANCED MEDICAL OPTICS, INC.
- ALCON LABORATORIES, INC.
- ALLERGAN, INC.
- BAUSCH & LOMB INC.
- CARL ZEISS AG
- CIBA VISION
- COOPERVISION, INC.
- MERCK & CO., INC.
- NEW WORLD MEDICAL, INC.
- NIDEK CO., LTD.
- NOVARTIS INTERNATIONAL, AG
- PFIZER, INC.
- STAAR SURGICAL CO.
- VISTAKON
APPENDIX: OPHTHALMIC PRODUCT MANUFACTURERS
- LIST OF OPHTHALMIC PRODUCT MANUFACTURERS
LIST OF TABLES
- Summary Table:
- U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
- Table 2 GLAUCOMA TYPES AND KEY POINTS
- Table 3 KNOWN CAUSES OF UVEITIS
- Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
- Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
- Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR MANUFACTURERS
- Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED STATES FOR 2005 ($)
- Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
- Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA APPROVAL DATE
- Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER AND DEVELOPMENT PHASE, 2006
- Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
- Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA APPROVAL DATE
- Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
- Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
- Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
- Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (PERCENT/$ MILLION)
- Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURER REVENUES, 2006 ($ MILLION)
- Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
- Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
- Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
- Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011 ($ MILLION)
- Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
- Table 29 MICROKERATOME/FEMTOSECOND SYSTEMS BY MANUFACTURER
- Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
- Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
- Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
- Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
- Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
- Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
- Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
- Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
- Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
- Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
- Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
- Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS, 2006-2019
- Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
LIST OF FIGURES
- Summary Figure:
- U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
- Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
- Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (%)
- Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURERS REVENUES, 2006 (%)
- Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
- Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%)
- Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
- Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (%)
- Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011 ($ MILLION)
- Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
- Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (%)
- Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($ MILLION)
- Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($ MILLION)
- Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)

The U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics,and Surgical Equipment

Table of Contents